For the Inventor, By the Inventor

Enter assignee name

San Antonio, TX, United States of America

Osteoscreen, Inc.

Calculating rank

USPTO Granted Patents = 28

% Expired Patents = 17.9

EPO Patents = 1

Forward Citations = 1,123

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Gregory R Mundy (24 out of 40 patents)

I Ross Garrett (12 out of 13 patents)

Kirk G Robbins (12 out of 19 patents)

4. Nand Baindur (12 out of 30 patents)

5. Charles R Petrie (10 out of 26 patents)

6. Mark W Orme (9 out of 68 patents)

7. Jorge Gianny Rossini (7 out of 10 patents)

8. Maria Kontoyianni (5 out of 7 patents)

9. Scott M Harris (3 out of 13 patents)

10. Gloria Gutierrez (3 out of 4 patents)

11. Virender M Labroo (2 out of 25 patents)

12. Wolfgang E Gallwitz (2 out of 2 patents)

13. Robert R West (2 out of 16 patents)

14. Theresa Martinez (2 out of 10 patents)

15. Shirley R Gasper (2 out of 6 patents)

Core Competencies:

Bone Growth

Nitric Oxide

Triterpenoids

Proteasomal Inhibitors

Hair Growth

Osteogenic Agents

Myeloma Bone Disease

Benzothiazole

Nutritional Supplements

Compositions

Methods

Screening Assay

28 patents: Sort by Forward Citations

1. 8299046 - Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth (2012-10-30),

2. 7678395 - Stimulation of hair growth by isoginkgetin (2010-03-16),

3. 7288535 - Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (2007-10-30),

4. 7223554 - Inhibitors of proteasomal activity for stimulating hair growth (2007-05-29),

5. 6958220 - Inhibitors of proteasomal activity for stimulating hair growth (2005-10-25),

6. 6902721 - Inhibitors of proteasomal activity for stimulating bone growth (2005-06-07),

7. 6884769 - Inhibitors of proteasomal activity for stimulating hair growth (2005-04-26),

8. 6838436 - Inhibitors of proteasomal activity for stimulating bone growth (2005-01-04),

9. 6838252 - Inhibitors of proteasomal activity for stimulating hair growth (2005-01-04),

10. 6656904 - Inhibitors of proteasomal activity for stimulating bone and hair growth (2003-12-02),

11. 6492333 - Treatment of myeloma bone disease with proteasomal and NF-&kgr;B activity inhibitors (2002-12-10),

12. 6462019 - Inhibitors of proteasomal activity and production for stimulating bone growth (2002-10-08),

13. 6413998 - Compositions and methods for treating bone deficit conditions (2002-07-02),

14. 6410521 - Nutritional supplements for stimulating bone growth (2002-06-25),

15. 6410512 - Inhibitors of proteasomal activity for stimulating hair growth (2002-06-25),

Company Overview

Osteoscreen, Inc. is a biotechnology company based in San Antonio, Texas, specializing in innovative solutions for bone health and osteoporosis management. The organization focuses on developing advanced diagnostic tools and therapeutic products aimed at improving patient outcomes in the field of bone density assessment and fracture risk evaluation. With a commitment to research and development, Osteoscreen leverages cutting-edge technology to enhance the understanding and treatment of skeletal health issues.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

28 Patents

#22 in San Antonio, TX

#675 in Texas

#12,036 in US

#23,351 in the World

San Antonio, TX, United States of America

Osteoscreen, Inc.

Forward Citations = 1,123

30 inventors:

Gregory R Mundy (24 out of 40 patents)

I Ross Garrett (12 out of 13 patents)

Kirk G Robbins (12 out of 19 patents)

4. Nand Baindur (12 out of 30 patents)

5. Charles R Petrie (10 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Osteoscreen, Inc.. Retrieved from https://idiyas.com/company/osteoscreen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…